» Articles » PMID: 29641598

Fasudil Improves Endothelial Dysfunction in Rats Exposed to Chronic Intermittent Hypoxia Through RhoA/ROCK/NFATc3 Pathway

Overview
Journal PLoS One
Date 2018 Apr 12
PMID 29641598
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial dysfunction is one of the main pathological changes in Obstructive sleep apnoea (OSA). The Rho kinase (ROCK) pathway is associated with endothelial dysfunction. However, the interaction between ROCK and nuclear factor of activated T cells isoform c3 (NFATc3) in the development of this pathological response under chronic intermittent hypoxia (CIH) is unclear. To simulate the OSA model, we established a moderate CIH rat model by administering the fraction of inspired O2 (FiO2) from 21% to 9%, 20 times/h, 8 h/day for 3 weeks. Fasudil (ROCK inhibitor, 8 mg/kg/d, i.p.) was administrated in the rats exposed to CIH for 3 weeks. Our results demonstrated that CIH caused significantly endothelial dysfunction, accompanying with increased ET-1 level, decreased eNOS expression and NO production, which reduced ACh-induced vascular relaxation responses. Moreover, RhoA/ROCK-2/NFATc3 expressions were up-regulated. Fasudil significantly improved CIH induced endothelial dysfunction. Data suggested that the ROCK activation is necessary for endothelial dysfunction during CIH.

Citing Articles

Effect of aortic smooth muscle BK channels on mediating chronic intermittent hypoxia-induced vascular dysfunction.

Zhang P, Zou P, Huang X, Zeng X, Liu S, Liu Y Korean J Physiol Pharmacol. 2024; 28(5):469-478.

PMID: 39198227 PMC: 11361999. DOI: 10.4196/kjpp.2024.28.5.469.


Intermittent hypoxia increased the expression of ESM1 and ICAM-1 in vascular endothelial cells via the downregulation of microRNA-181a1.

Takasawa S, Makino M, Yamauchi A, Sakuramoto-Tsuchida S, Hirota R, Fujii R J Cell Mol Med. 2023; 28(1):e18039.

PMID: 37968862 PMC: 10805502. DOI: 10.1111/jcmm.18039.


Danggui-Buxue decoction alleviated vascular senescence in mice exposed to chronic intermittent hypoxia through activating the Nrf2/HO-1 pathway.

Li D, Si J, Guo Y, Liu B, Chen X, Qi K Pharm Biol. 2023; 61(1):1041-1053.

PMID: 37431236 PMC: 10337509. DOI: 10.1080/13880209.2023.2230753.


New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer's Disease.

Hao Y, Xie B, Fu X, Xu R, Yang Y Biomolecules. 2022; 12(12).

PMID: 36551230 PMC: 9775548. DOI: 10.3390/biom12121802.


TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment.

Ning H, Zhang L, Zhu B, Zhou X, Zhang T, Ma T Cell Death Dis. 2022; 13(5):457.

PMID: 35562351 PMC: 9106673. DOI: 10.1038/s41419-022-04920-8.


References
1.
Shin H, Salomone S, Potts E, Lee S, Millican E, Noma K . Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J Cereb Blood Flow Metab. 2006; 27(5):998-1009. PMC: 2614438. DOI: 10.1038/sj.jcbfm.9600406. View

2.
Sugimoto M, Nakayama M, Goto T, Amano M, Komori K, Kaibuchi K . Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem Biophys Res Commun. 2007; 361(2):462-7. DOI: 10.1016/j.bbrc.2007.07.030. View

3.
Wang Q, Stalker T, Gong Y, Rikitake Y, Scalia R, Liao J . Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med. 2012; 17(6):379-85. PMC: 3807093. DOI: 10.1177/1358863X12459790. View

4.
Pietropaoli N, Supino M, Vitelli O, Rabasco J, Evangelisti M, Forlani M . Cognitive function in preschool children with sleep-disordered breathing. Sleep Breath. 2015; 19(4):1431-7. DOI: 10.1007/s11325-015-1157-3. View

5.
Zamarron C, Valdes Cuadrado L, Alvarez-Sala R . Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome. Pulm Med. 2013; 2013:521087. PMC: 3712227. DOI: 10.1155/2013/521087. View